Ono Pharmaceutical Co Ltd
Ono Pharmaceutical's Climate Target Data Preview
As of 2024, Ono Pharmaceutical has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 3 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Ono Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2035 |
Absolute-based Target* | Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2050 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Ono Pharmaceutical's Greenhouse Gas Emissions Pathways
As of 2024, Ono Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Ono Pharmaceutical have a target to reduce the emissions from its operations?
As of 2024, Ono Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Ono Pharmaceutical's most ambitious operational target is to reduce these emissions by 100% by 2035, compared to a baseline of 29,800 Metric Tonnes of CO2 equivalent (mtCO2e) in 2017.
As of 2023, Ono Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 46.2% of the planned reduction.
Ono Pharmaceutical's Operational (Scope 1+2) Emissions Pathway
Does Ono Pharmaceutical have a target to reduce the emissions from its value chain?
As of 2024, Ono Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 4 out of the 15 Scope 3 categories defined by the GHG Protocol.
Ono Pharmaceutical's most ambitious value chain target is to reduce these emissions by 60% by 2050, compared to a baseline of 75,100 Metric Tonnes of CO2 equivalent (mtCO2e) in 2017.
As of 2023, Ono Pharmaceutical is ahead of schedule on its value chain emissions reduction target, having achieved 77.9% of the planned reduction.